Page last updated: 2024-08-16

pioglitazone and ramipril

pioglitazone has been researched along with ramipril in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cersosimo, E; Cusi, K; DeFronzo, R; Fernandez, M; Musi, N; Sriwijilkamol, AA; Triplitt, C; Wajcberg, E1
Berry, C; Bourassa, MG1
Dekordi, LA; Forst, T; Fuchs, W; Hanefeld, M; Kleine, I; Müller, J; Pfützner, A1
Cernecka, H; Goris, M; Henning, RH; Klimas, J; Krenek, P; Kyselovic, J; Mesarosova, L; Ochodnicky, P; van Dokkum, RP1

Reviews

1 review(s) available for pioglitazone and ramipril

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for pioglitazone and ramipril

ArticleYear
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.
    Diabetes care, 2008, Volume: 31, Issue:1

    Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Forearm; Glucose Clamp Technique; Glycated Hemoglobin; Hispanic or Latino; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Infusion Systems; Pioglitazone; Placebos; Ramipril; Thiazolidinediones

2008
Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.
    Journal of diabetes science and technology, 2011, Jul-01, Volume: 5, Issue:4

    Topics: Adult; Aged; Antihypertensive Agents; Biomarkers; Blood Vessels; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Inflammation; Male; Middle Aged; Pioglitazone; Placebos; Ramipril; Risk Factors; Severity of Illness Index; Thiazolidinediones; Up-Regulation

2011

Other Studies

3 other study(ies) available for pioglitazone and ramipril

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.
    Current atherosclerosis reports, 2008, Volume: 10, Issue:2

    Topics: Antihypertensive Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Humans; Hyperglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Life Style; Myocardial Infarction; Obesity; Pioglitazone; Piperidines; Platelet Aggregation Inhibitors; Prediabetic State; Pyrazoles; Ramipril; Rimonabant; Risk Assessment; Thiazolidinediones; Triglycerides; Weight Loss

2008
Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat.
    European journal of pharmacology, 2014, May-05, Volume: 730

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Disease Progression; Doxorubicin; Endothelium, Vascular; Gene Expression Regulation; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Pioglitazone; PPAR gamma; Proteinuria; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Thiazolidinediones

2014